جست‌وجوی استاد و پژوهشگر

Katherine Hallمشاهده پروفایل

استادیار

• Nursing Education
• Public Health
• Mental Health
• +۳ مورد دیگر

Katherine Hall serves as an Assistant Professor at the University of Virginia School of Nursing, where she has been a clinical instructor since 2023. With over 16 years of nursing experience spanning orthopedics, leadership, and education roles, she teaches diverse courses including pharmacology, pathophysiology, community health, epidemiology, and critical care to undergraduate and graduate students across multiple programs (LPN, BSN, RN-to-BSN, ABSN, and CNL). Her academic credentials include: PhD in Nursing from the University of Virginia (2024) MSN in Nursing Education from Duke University BSN from West Virginia University Dr. Hall's research centers on the concept of "mattering" for nurses in healthcare environments, investigating burnout and professional fulfillment through interdisciplinary lenses. Her work integrates nursing education, mental health resilience, public health initiatives, and ethical frameworks, with particular emphasis on pandemic impacts and innovative teaching methodologies. She champions student-centered approaches that address personal, professional, and ethical development. Her publication portfolio reveals strong thematic continuity in addressing systemic challenges in nursing: pandemic-related stressors on educational and clinical practice, technology integration in health professions training, and ethical dimensions of digital communication. These works collectively advance understanding of nurse well-being through community health applications, educational innovation, and social determinants of professional satisfaction. As an educator, Dr. Hall has mentored diverse student cohorts across global clinical settings including the Jefferson Area Board for Aging and Clinica Esperanza in Honduras. Her dissertation on "mattering" directly informs her teaching philosophy of meeting learners at their individual points of need while fostering holistic professional growth.

Matthew Gloverمشاهده پروفایل

پژوهشگر ارشد

• Health Economics
• Decision Modelling
• Clinical Trials
• +۳ مورد دیگر

Matthew Glover is a Senior Research Fellow in Health Economics at the University of Surrey, part-time, affiliated with the School of Biosciences and the Surrey Health Economics Centre (SHEC). He holds a BA (Hons) in Economics from Durham University, an MSc in Health Economics from the University of York, and a PhD from Brunel University London, where his doctoral work focused on the role of economic modeling in health technology and research impact assessment. His research interests center on methods and applications of economic evaluation, health technology assessment, decision analytic modeling, and cost-effectiveness analysis of clinical trials across diverse therapeutic areas, including care home interventions, diabetes prevention, and oncology. Dr. Glover’s work emphasizes translating research into practical healthcare solutions, particularly through collaborations with industry and policy stakeholders. He has contributed to high-impact projects such as the PROTECT-CH trial evaluating prophylactic treatments for COVID-19 in care homes and the iHealth-T2D study addressing diabetes prevention in South Asian populations. His methodological expertise spans discrete event simulation, cost-effectiveness modeling, and realist evaluation approaches to assess healthcare quality improvement initiatives. Key areas of focus include optimizing nurse staffing in long-term care facilities, analyzing the economic implications of abdominal aortic aneurysm screening programs, and evaluating interventions in emergency medical services. His interdisciplinary approach bridges clinical research, health economics, and policy, aiming to enhance healthcare resource allocation and patient outcomes. Education: BA (Hons) in Economics, University of Durham MSc in Health Economics, University of York PhD in Health Economics, Brunel University London Key Research Themes: Health Technology Assessment Decision Modeling and Simulation Clinical Trial Cost-Effectiveness Analysis Care Home and Long-term Care Research Resource Allocation in Healthcare Labs/Teams: Surrey Health Economics Centre (SHEC) Collaborations with Health Economics Research Group (HERG), Brunel University

• Medical Genetics
• Clinical Cancer Genetics
• Personalized Medicine
• +۳ مورد دیگر

Jonathan S. Berg, MD, PhD, is the Bryson Distinguished Professor in the Departments of Genetics and Medicine at the University of North Carolina School of Medicine. He specializes in clinical and translational genetics, with a focus on cancer genetics and genomic medicine. His roles include Director of the Adult and Cancer Genetics Clinic and the Program in Precision Medicine in Healthcare. Dr. Berg completed his PhD (2001) and MD (2003) at UNC, followed by residency at Baylor College of Medicine (2007) and a postdoctoral fellowship (2009). He is a Fellow of the American College of Medical Genetics and Genomics and co-PI on major grants like ClinGen and NCGENES2. His research integrates next-generation sequencing for gene discovery, diagnostic testing, and population health initiatives, including the Age-Based Genomic Screening project addressing health disparities. Affiliations include the Lineberger Comprehensive Cancer Center and Carolina Institute for Developmental Disabilities. Research interests span clinical translation of genetic technologies, cancer predisposition genetics, and the cost-benefit analysis of predictive testing. Key contributions include advancing newborn genomic screening and understanding structural variants in cancer. His lab collaborates broadly, with recent publications emphasizing genomic medicine applications and public health implications.

Melissa Haendelمشاهده پروفایل

استاد

• Rare Disease
• Real World Data
• Ontologies
• +۵ مورد دیگر

Melissa Haendel, PhD, FACMI is the Sarah Graham Kenan Distinguished Professor of Genetics at the UNC School of Medicine, serving as Director of Precision Health & Translational Informatics and Deputy Director of Computational Science at NC TRACS. Her research focuses on Rare Diseases, Real World Data, Ontologies, Semantics, and Precision Medicine through the Translational and Integrative Sciences Laboratory (TISLab). She leads global efforts in phenomics, clinical data integration, and open science frameworks like uPheno and MONDO disease alignment. Dr. Haendel has been awarded the 2024 Leading for IMPACT – Women in Leadership Award and is a Fellow of the American College of Medical Informatics. Her lab’s work spans rare diseases, Down Syndrome, cancer, and public health challenges such as pandemic response and climate change. Recent projects include the NIH-funded RM1 grant for phenomics-first variant interpretation and the ARPA-H subcontract CHARM toolchain. She oversees the Center for Linkage and Acquisition of Data (CLAD), advancing All of Us Research Program data integration via cloud-based platforms. Dr. Haendel has secured over $19M in NIH grants and collaborates across disciplines including epidemiology, data science, and pediatrics. Her postdoctoral mentorship includes Dr. Eric Hurwitz, co-author of studies on postpartum depression screening using wearable devices. Key collaborations involve UNC’s TraCS, Sheps Center, and external partners like OCHIN and Datavant to address health disparities through data-driven solutions.

Stephen Duffyمشاهده پروفایل

استاد

• Cancer Screening
• Epidemiology
• Biostatistics
• +۷ مورد دیگر

Professor Stephen Duffy is a leading academic in cancer screening and statistical research at Queen Mary University of London (QMUL), affiliated with the Wolfson Institute of Population Health. He has conducted pivotal work in randomized trials of cancer screening programs, including foundational studies like the Swedish Two-County Trial (basis for UK breast screening) and the UK Lung Screening Trial. His current role as Director of the Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis since 2010 involves collaboration across seven institutions to advance early cancer detection strategies. Trained at the University of Edinburgh and Imperial College London, his expertise spans biostatistics, epidemiology, and public health. His research focuses on improving screening efficacy through innovations such as AI-driven risk assessment, optimizing screening intervals, and addressing barriers to participation. He also explores the societal impact of screening, including cost-effectiveness and socio-economic disparities in program outcomes. Professor Duffy’s scientific contributions include twice receiving the Alexander Margulis Prize for Scientific Excellence from the Radiological Society of North America. His work integrates behavioral science to enhance screening uptake and examines the role of social media in cancer awareness. Additionally, he investigates the ecological and genomic implications of invasive species and zoonotic diseases, reflecting his interdisciplinary approach to health challenges. His grants and leadership roles highlight extensive collaborations, such as the NIHR School for Primary Care Research and the Department of Health-funded Policy Research Unit. He leads efforts to refine colorectal and lung cancer screening protocols while advocating for equitable access to healthcare interventions. His team’s work on artificial intelligence and symptom-driven diagnostics underscores a commitment to transforming cancer care through evidence-based practices.

Chad A. Shawمشاهده پروفایل

استاد

• Statistics
• Genomics
• Systems Biology
• +۳ مورد دیگر

Chad A. Shaw is a Professor at Baylor College of Medicine and a Joint Professor of Statistics at Rice University. He serves as Director of the D2K Laboratory at Rice, and holds additional roles including Investigator at the Jan and Dan Duncan Neurological Research Institute and Faculty Member at the Baylor College of Medicine’s STaR Center and Quantitative & Computational Biosciences program. His expertise spans statistical genomics, bioinformatics, and molecular genetics. Education: BS in Mathematics (Duke University, 1995); PhD in Statistics (Rice University, 2001). Research Interests: Focuses on statistical methods for genomics, including next-generation sequencing analysis, structural variation studies, and clinical exome sequencing. Key contributions include probabilistic models for mutation transmission in human genetic diseases, copy-number variation analysis, and functionalization of genetic variants. His work bridges computational statistics with clinical applications, addressing challenges in rare disease diagnostics and Mendelian disorder modifiers. Publications: Over 200 peer-reviewed articles, including foundational studies on recurrence risk in genetic disorders and mechanisms of structural variation. Recent work emphasizes Bayesian modeling in sequencing assays, CNV-driven genetic diseases, and prenatal genomic analysis. Awards/Grants: No explicit awards mentioned, but his research has been cited ~17,000 times. Active in grant-funded projects across computational and clinical genomics. Advising: Trained 5 PhD students and advised over 10 others, with students contributing to areas like high-dimensional regression and software tools for variant prioritization. Labs/Teams: Leads the D2K Laboratory at Rice, fostering interdisciplinary research in data science and computational biology.

Geneviève C. Digbyمشاهده پروفایل

دانشیار

• Lung Cancer
• Health Systems
• Public Health
• +۳ مورد دیگر

Dr. Geneviève C. Digby is an Associate Professor in the Department of Medicine at Queen’s University, with a cross-appointment in the Department of Oncology. She serves as the Interim Co-Chair of the Division of Respirology and holds roles such as Medical Director for Patient Safety, Quality, and Clinical Risk at Kingston Health Sciences Centre. Her clinical expertise includes respirology, bronchoscopy, and lung cancer diagnostics, particularly leading the Lung Diagnostic Assessment Program. She is dedicated to Quality Improvement (QI) in healthcare, focusing on streamlined care processes and resource optimization for cancer patients. Dr. Digby completed her medical training at Queen’s University, including a residency in Internal Medicine, a fellowship in Respirology, and an MSc in Healthcare Quality. Education: MD, Queen’s University (2010) Residency in Internal Medicine, Queen’s University (2013) Fellowship in Respirology, Queen’s University (2015) MSc in Healthcare Quality, Queen’s University (2016) Her research interests span Lung Cancer, Healthcare Quality Improvement, Patient-Centered Care, and Respirology. She has been recognized with awards such as the Dr. D. Laurence Wilson Professionalism Award (2020) and the Outstanding Mid-Career Physician Award (2023). Dr. Digby leads multiple committees, including the Physician Quality Committee and the Department of Medicine Quality Improvement and Patient Safety Committee, demonstrating her commitment to advancing healthcare systems and patient outcomes.

Joseph Gregory Rosenمشاهده پروفایل

استادیار

• HIV Prevention, Care & Treatment
• Implementation Science
• Drug Overdose Prevention
• +۴ مورد دیگر

Dr. Joseph Gregory Rosen is an Assistant Professor of Epidemiology (Research) and Medicine (Research) at Brown University’s School of Public Health, and a Research Scientist at Rhode Island Hospital’s Division of General Internal Medicine. His work focuses on implementation science at the intersection of HIV treatment/prevention and substance use services. Key roles include Principal Investigator for studies on HIV treatment delivery in Uganda, overdose detection technologies in Massachusetts, and substance use service linkage for female sex workers in South Africa. He holds affiliations with the Providence/Boston Center for AIDS Research and Brown’s BRIDGE Program. Education: PhD in Social and Behavioral Interventions (Johns Hopkins University, 2023) MSPH in Public Health (Johns Hopkins, 2018) BA in Sociology (Bowdoin College, 2014) Research Interests: Rosen’s research emphasizes health workforce capacity-building and system reconfiguration to improve HIV/harm reduction services for marginalized groups, including sex workers, people who use drugs, and justice-involved individuals. Methodological strengths include human-centered design, discrete choice experiments, latent variable modeling, and qualitative methods. His work spans sub-Saharan Africa and the U.S., addressing topics like viral load monitoring, overdose prevention technologies, and PrEP implementation. Grants & Awards: NIH/NIDA (R21DA056304): Studying substance use and ART adherence among female sex workers in South Africa Bloomberg Philanthropies: Overdose detection sensor feasibility study in housing facilities Recipient of multiple NIH awards, including an NIMH F31 fellowship and NIAID CFAR grants Labs/Teams: Leads the Brown Implementation Science/HIV Scientific Working Group and collaborates with global organizations like UNICEF and Médecins Sans Frontières. His work is published in journals such as Addiction , Clinical Infectious Diseases , and JAIDS .

Jeffrey V Lazarusمشاهده پروفایل

استاد

• Public Health Liver Policy
• Liver Health Epidemiology
• Models of Care for Liver Disease
• +۱۲ مورد دیگر

Prof Jeffrey V Lazarus is a Full Professor at the CUNY Graduate School of Public Health and Health Policy and Associate Professor at the University of Barcelona. He leads the Public Health Liver Group at ISGlobal and holds affiliations with multiple global health institutions. He previously served as Professor at LUHS Medical Academy (Lithuania), Affiliated Professor at CHIP (University of Copenhagen), and at the University of Porto, Portugal. His research focuses on public health liver policy, liver health epidemiology, models of care for steatotic liver disease, economic analyses, and person-centered care . He is a leading expert in MASLD/MASH and viral hepatitis, with a strong emphasis on health systems and global policy. His work bridges clinical hepatology with public health implementation and equity. His recent publications reveal a dominant focus on metabolic dysfunction-associated steatotic liver disease (MASLD/MASH) , including global prevalence, policy indices, diagnostic strategies, economic burden, and disparities. He also leads major consensus initiatives in COVID-19, HIV, and viral hepatitis elimination , often using Delphi methods and modeling approaches. His work is highly policy-relevant and published in top journals like Nature , The Lancet , and Journal of Hepatology . American Liver Foundation Distinguished Scientific Achievement Award (2023) Clarivate Highly Cited Researcher (2024) Eugene T. Davidson, MD, Public Service Award (2025) He is principal investigator on multiple global consensus statements and funded projects including MASLD/MASH Best Buys, Doubling the Diagnosed, the Global MASLD/MASH Policy Index, VH-COMSAVAC, and LiverAIM. He has advised WHO, the Global Fund, and numerous governments. He co-chairs the Innovations in SLD Think-tank and chairs the Wilton Park NAFLD meetings. He is on the editorial boards of the Journal of Hepatology and Liver International . He leads the Global Think-tank on Steatotic Liver Disease , MASH Cities , and the Healthy Livers, Healthy Lives coalition, all of which focus on translating research into policy and community action for liver health.

Cynthia Mastickمشاهده پروفایل

دانشیار

• Cell Biology
• Biochemistry
• Diabetes
• +۵ مورد دیگر

Cynthia Mastick is an Associate Professor in the Department of Biology at the University of Nevada, Reno, with a research focus on the biochemistry and cell biology of adipose tissue and its role in diabetes and metabolic diseases. She has held academic positions in the Department of Pharmacology (2016-2020) and the Department of Biochemistry and Molecular Biology (1998-2016) at the University of Nevada, Reno School of Medicine (UNRMed). Prior to her academic career, she worked as a Senior Scientist at Parke-Davis Pharmaceutical Research (1993-1998). Ph.D. in Biochemistry, Carnegie Mellon University (1990) B.S. in Biology, Carnegie Mellon University (1985) Her research explores how sympathetic innervation regulates fat mobilization in adipose tissue, particularly through insulin-stimulated GLUT4 trafficking and caveolin phosphorylation. She has co-developed interdisciplinary programs like the Biotechnology BS/MS degree and contributed to curriculum design in medical education. Dr. Mastick's work spans molecular mechanisms in diabetes and metabolic diseases, utilizing adipocyte models and advanced cellular imaging techniques. Analysis of her publications reveals trends in understanding insulin-regulated glucose transport, Rab GTPase roles in vesicle sorting, and stress-induced signaling pathways. She has authored studies on caveolin phosphorylation, syntaxin-4 knockout effects, and comparative trafficking mechanisms across cell types. Laboratory: FA 315, University of Nevada, Reno

Linda Juel Ahrenfeldtمشاهده پروفایل

دانشیار

• General Practice
• Public Health
• Aging Research
• +۱۰ مورد دیگر

Linda Juel Ahrenfeldt is an Associate Professor at the Department of Public Health, University of Southern Denmark, where she is affiliated with the Research Unit of General Practice. Her work spans research, teaching, and supervision, with a strong focus on aging, gender differences in health, sensory impairments, and continuity in primary care. University: University of Southern Denmark School: Department of Public Health Department: Research Unit of General Practice Academic Rank: Associate Professor Email: lahrenfeldt@health.sdu.dk Her research interests include aging research, mental health in older adults, sex differences in mortality, sensory impairments, and physician training in general practice. She employs longitudinal and cohort methodologies to explore how social, biological, and healthcare factors influence health outcomes in aging populations. Her work frequently uses Danish national registries and international datasets like SHARE. The 15 most recent articles reflect a consistent focus on public health, epidemiology, and primary care. Key themes include cardiovascular and cancer outcomes, vaccine acceptance, sensory impairments, and mental health in older adults. Methodologically, her research emphasizes cohort analysis, regression modeling, and longitudinal design, contributing significantly to understanding health disparities and healthcare delivery. Peer reviewer for: Aging & Mental Health, European Journal of Clinical Investigation, PeerJ, Archives of Public Health Active participant in conferences and workshops, including Symposium i Anvendt Statistik Linda Juel Ahrenfeldt supervises multiple PhD and research projects, including AVID (visually impaired individuals), cancer diagnostic pathways, and health among seafarers. She has co-supervised and managed several interdisciplinary projects, often in collaboration with researchers from ophthalmology, epidemiology, and social medicine. Her teaching includes biostatistics, epidemiology, and public health, contributing to both undergraduate and postgraduate education. She leads and participates in research labs and teams focused on general practice, aging, and sensory health, fostering collaboration across disciplines. Her work has policy implications, particularly in primary care improvement and aging societies.

• Digestive Diseases
• Epidemiology
• Gastroenterology
• +۵ مورد دیگر

Eivind Ness-Jensen is an Associate Professor and Project Manager at the HUNT Research Center, Department of Community Medicine and Nursing, NTNU. He leads the HUNT5 project (projected 2027-2029) and the HUNT celiac disease initiative, funded by the Research Council of Norway. Education: Specialist in Internal Medicine & Digestive Diseases (2017), PhD in Public Health (2014, NTNU), Cand. med. (2005, University of Oslo). Professional roles include Senior Physician at Levanger Hospital and Postdoc at Karolinska Institutet (2014-2018). Research focuses on epidemiology of digestive diseases, including celiac disease, GERD, inflammatory bowel disease, and digestive tract cancers. Key projects include population-based studies using the HUNT cohort and Nordic health registries. Awards include the 2021 Health Central Norway RHF Research Award and membership in NTNU’s Star Program 3.0 (2019-2023). He also holds leadership roles in the Norwegian Gastroenterological Association and Research Committee, Health Nord-Trøndelag. Teaching responsibilities include medical students at NTNU/St. Olavs Hospital and NTNU Link/Levanger Hospital. Active in supervising PhD, master’s, and medical students.

• Geriatrics
• Pulmonary Medicine
• Respiratory Health
• +۷ مورد دیگر

Dr. Leah Witt is an Associate Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. She serves as the Pulmonary Associate Chief for Ambulatory Affairs since 2021 and a Fellowship Coach for the Pulmonary & Critical Care Medicine Fellowship Program at UCSF since 2022. Her roles emphasize clinical care, education, and translational research at the intersection of geriatrics and pulmonary medicine. Education and Training: B.A. in Anthropology and Global Health (Northwestern University, 2007) M.D. (University of Minnesota Medical School, 2011) Internal Medicine Residency (University of Chicago, 2014) Pulmonary Medicine Fellowship (University of Chicago, 2017) Geriatrics Fellowship (UCSF, 2018) Completed Diversity, Equity, and Inclusion Champion Training (UCSF) Research interests focus on geriatric care for older adults with chronic lung diseases, including COPD and interstitial lung disease. She explores metabolic pathways in pulmonary fibrosis, frailty biomarkers, and interprofessional education strategies. Her work highlights aging-related respiratory comorbidities and the integration of geriatric principles into pulmonary medicine. Her recent articles address COPD management, metabolic mechanisms in lung fibroblasts, and ethical healthcare rationing. These publications reflect her dual expertise in clinical practice and geriatric research. Awards include the HRSA Geriatric Academic Career Award (2019–2023), UCSF Geriatrics Teacher of the Year (2022), and induction into the Academy for Medical Educators (2024). Dr. Witt’s advising and grant activities include leading the HRSA-funded project on interprofessional geriatrics education. She collaborates with teams in pulmonary medicine, critical care, and geriatrics. Her professional service includes roles in academic senate committees and clinical trial oversight. Labs/Teams: Active member of UCSF’s Pulmonary & Critical Care Medicine and Geriatrics teams. Collaborates with interdisciplinary groups focused on aging-related respiratory diseases and palliative care co-management strategies.

Suzanne Willeyمشاهده پروفایل

مدرس ارشد

• Midwifery
• Public Health and Health Promotion
• Migrant and Refugee Women Health
• +۳ مورد دیگر

Suzanne Willey is a Senior Lecturer in the School of Nursing and Midwifery at Monash University. She holds a PhD in Public Health (2020) from Monash University, focusing on perinatal mental health screening for refugee women. Her research emphasizes midwifery practices, public health, and health equity, particularly for migrant and refugee populations. She has led and contributed to multiple projects addressing maternal and child health disparities, including improving access to care for Aboriginal women and evaluating refugee health programs. Willey’s work aligns with UN Sustainable Development Goals related to health and well-being. Her projects include projects like ‘Improving access and equity in maternity care for Aboriginal women’ (2021–2023) and ‘Evaluation of The Victorian Refugee Health Program’ (2020). She has supervised Masters students and contributed to interprofessional education initiatives. Her research outputs span peer-reviewed articles on topics such as perinatal mental health screening for refugee women, systemic racism in healthcare, and midwifery education. Key collaborations include work with institutions like Cabrini Health Limited and projects funded by organizations prioritizing health equity. Willey’s contributions extend to clinical guidelines, such as the ‘Promoting Refugee Health’ guide, and she actively participates in interdisciplinary teams to address health inequities through qualitative and program evaluation methods.

• Cancer Research
• Structural Biology
• NMR Spectroscopy
• +۳ مورد دیگر

Ridvan Nepravishta serves as an Honorary Lecturer in the School of Molecular Biosciences and Affiliate of Beatson Associates in the School of Cancer Sciences at the University of Glasgow, conducting research at the CRUK Scotland Institute (formerly CRUK Beatson Institute). His work bridges cancer biology and structural biochemistry through advanced NMR methodologies. His research program centers on protein-ligand interactions and cancer target validation , with dual emphases on: Methodological innovation in NMR spectroscopy (rd-STD, DEEP-STD, SDTD) for characterizing weak biomolecular complexes Translational cancer research focusing on Ras inhibitors, thymosin α1 immunomodulation, and bacterial metabolism pathways relevant to oncology Key contributions include developing accelerated NMR techniques for drug discovery and elucidating mechanisms of protein conformational changes in oncogenic targets. Analysis of his 15 most recent publications (2020-2025) reveals three dominant research trajectories: 1) Ras protein inhibition strategies spanning conformational state-specific targeting, 2) NMR method development for weak binding validation, and 3) structural characterization of immune modulators like thymosin α1. His work consistently integrates biophysical techniques with cancer biology to address drug discovery challenges. While no formal advising roles or specific grants are documented in available materials, his extensive collaboration with the CRUK Scotland Institute indicates active participation in cancer research consortia. His laboratory work focuses on NMR-based structural analysis of protein complexes relevant to oncology and infectious disease.